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Abstract
In pig, very little information is available on the non classical class I (Ib) genes of the Major Histocompatibility
Complex (MHC) i.e. SLA-6, -7 and -8. Our aim was to focus on the transcription pattern of the SLA-7 gene. RT-PCR
experiments were carried out with SLA-7 specific primers targeting either the full coding sequence (CDS) from
exon 1 to the 3 prime untranslated region (3UTR) or a partial CDS from exon 4 to the 3UTR. We show that the
SLA-7 gene expresses a full length transcript not yet identified that refines annotation of the gene with eight exons
instead of seven as initially described from the existing RefSeq RNA. These two RNAs encode molecules that differ
in cytoplasmic tail length. In this study, another SLA-7 transcript variant was characterized, which encodes a protein
with a shorter alpha 3 domain, as a consequence of a splicing site within exon 4. Surprisingly, a cryptic non
canonical GA-AG splicing site is used to generate this transcript variant. An additional SLA-7 variant was also
identified in the 3UTR with a splicing site occurring 31 nucleotides downstream to the stop codon. In conclusion,
the pig SLA-7 MHC class Ib gene presents a complex transcription pattern with two transcripts encoding various
molecules and transcripts that do not alter the CDS and may be subject to post-transcriptional regulation.
Background
The Major Histocompatibility Complex (MHC) class I
gene family comprises classical (Ia) and non classical
(Ib) genes. The highly polymorphic class Ia genes are
widely expressed and encode membrane-bound glyco-
proteins that present self and viral peptides to cytotoxic
T cells [1] and modulate the activity of natural killer
cells [2]. In contrast, the class Ib genes display limited
polymorphism, and are predominantly expressed in
immunotolerant organ sites in human, notably at the
feto-maternal interface [3]. In man, three MHC class Ib
genes have been characterized, namely HLA-E,- F and
-G[3] and HLA-G has been shown to express alterna-
tively spliced variants encoding various membrane-
bound as well as soluble proteins [4]. In mouse, the H2-
QaI gene is orthologous to HLA-E[5] and functional
homologies have been established between H2-Qa2 and
HLA-G[6]. One to four MHC class Ib genes have been
identified in rat according to haplotypes [7] and four
MHC class Ib genes have been characterized in cattle
[8]. There is a growing interest in addressing the role of
t h eM H Cc l a s sI bg e n e si nt h es p e c i e sw h e r et h e ya r e
characterized. Indeed, MHC class Ia genes seem to
share similar functions across species but the MHC
class Ib genes are good candidates to address questions
on both shared and species-specific immunity-related
roles.
In pig, very limited information is available on the
MHC class Ib genes SLA-6, -7 and -8. The three genes
have been fully sequenced from the homozygous Hp1a.0
haplotype [9,10]. Nine allelic variants have been
reported for SLA-6 and only two for SLA-7 or SLA-8
[11]. It has been shown that SLA-Ib genes are expressed
in a less restricted manner than the HLA-Ib genes
[12,13] despite a predominant transcription in the lym-
phoid organs, the lung and the digestive tract [13]. In
addition, conversely to the SLA-Ia genes, transfection
experiments have revealed that the promoters of SLA-7
and SLA-6 do not respond to interferon, suggesting dis-
tinct regulatory systems for pig MHC class Ia and Ib
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transcription of the SLA-7 gene known to have a unique
reference transcript [12]. In this report, we show that
the SLA-7 gene expresses a full-length transcript not yet
identified as well as at least two additional alternative
spliced variants that lead to either exon alteration in the
resulting protein or modification of the 3’end of the
transcript.
Methods
Animals, tissues and RNA extraction
Tissues from Melanoma-bearing Libechov Minipigs
(MeLiM) [15] and French Large White pigs were used.
The tissues from MeLiM pigs have been sampled on 13
months old animals. At the time of tissue sampling, all
MeLiM animals had regressed, meaning that they were
not bearing melanomas anymore [15]. Tissues included
brain, thymus, tonsil, spleen and liver. Total RNA was
extracted using QIAGEN RNeasy Mini Kits (Qiagen,
France). All RNA samples were purified by on-column
digestion of DNA with DNase I as recommended by the
manufacturer (Qiagen, France).
Primer design
Three primers were designed from the SLA-7 reference
cDNA [12] and genomic [9,10] sequences, using the
Primer3 online program [16]. The primer combina-
tions were suitable to amplify the full coding sequence
from exon 1 to the three prime untranslated region
(3UTR) or a partial coding sequence from exon 4 to
t h e3 U T R( T a b l e1a n dF i g u r e1 ) .P r i m e r sw e r ea l s o
designed to amplify cDNAs of the RPL32 gene that has
been used as control gene for expression levels (Table
1a n dF i g u r e1 ) .
RT-PCR and sequencing
Two micrograms of DNaseI-treated total RNA were
reverse-transcribed (Superscript II enzyme, Invitrogen,
USA) with Oligo (dT) primers in a final volume of 20
µL to which 30 µL of water were further added to pre-
pare the stock solution of RT samples. PCRs were car-
ried out in a final volume of 15 µL using 100 nM of
each primer, 1 µL of the 1:10 RT sample and the
GoTaq™ DNA polymerase (Promega, USA). Thermocy-
cling conditions were as follows: 94°C for 3 min,
followed by 35 amplification cycles at 94°C for 30 sec,
60°C for 30 sec and 72°C for 90 sec, followed by a final
extension at 72°C for 5 min. The PCR products were
purified using the JETQUICK Gel Extraction Spin Kit
(Genomed, Germany) for further cloning into pCR2.1
vector (TA Cloning Kit, Invitrogen, USA) and sequen-
cing (Eurofins MWG Operon, France).
Sequence analysis
Sequence similarities were searched with the BLAST
tools [17]. Multiple alignments were carried out with
CLUSTALW [18]. cDNA sequences were translated to
protein by online DNA to Protein translation tool
(http://bio.lundberg.gu.se/edu/translat.html).
Results and discussion
SLA-7 full coding sequences
Full length SLA-7 transcripts were characterized by RT-
PCR from the thymus of MeLiM pigs using the primers
SLA-7-e1-F and SLA-7-3UTR-R (Table 1 and Figure 1).
A 1465 nucleotides long transcript was obtained and
further named SLA-7-1465 (Accession number:
GU322918). Annotation was carried out by aligning the
cDNA sequence to the genomic reference sequence
(GenBank accession number AJ251914) and eight exons
were detected in this new transcript, in contrast to the
reference full-length transcript (Accession number
NM_213768) that harbours only seven exons [12] (Fig-
ure 1) and is referred to as SLA-7-001 (OTT-
SUST00000000782) in the Vertebrate Genome
Annotation database [19]. The two RNAs encode pro-
teins that differ in the cytoplasmic tail (Figure 2). The
SLA-7-001 encoded protein contains a cytoplasmic tail
that is defined by exons 6 and 7 and is 68 aminoacids
long. The SLA-7-1465 encoded protein is characterized
by a cytoplasmic tail that is defined by exons 6 to 8 and
is 55 aminoacids long. It has been demonstrated that
the cytoplasmic tail of MHC class I molecules contri-
butes to their expression on the cell surface [20] and
that mutations of cysteine residues in the cytoplasmic
tail of MHC class Ia molecules modify extracellular
recognition by Leukocyte Ig-Like receptor 1 [21]. More-
over, it has been reported that HLA-F molecules are
entirely dependent on the cytoplasmic tail for export
from the endoplasmic reticulum to the Golgi apparatus
Table 1 RT-PCR primers
Genes Primer name Sequence of primers (5’-3’) Position of primers Accession numbers
SLA-7 SLA-7-e1-F ATGGGGCCCCGAGCCCTCCTCCT Exon1
SLA-7-e4-F TGGAGAGGAGCAGAGCTACA Exon4 AJ251914
SLA-7-3UTR-R AGAGCCACTGCTGATCCAGT 3’UTR AY463541
RPL32 RPL32-F TGCTCTCAGACCCCTTGTGAAG Exon1
RPL32-R TTTCCGCCAGTTCCGCTTA Exon2 NM_001001636
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Page 2 of 6[22]. Altogether, these reports strongly support a major
role for the cytoplasmic tail of MHC class I molecules
in transport and function. Further experiments are
required to study whether the SLA-7 molecules encoded
by SLA-7-001 or SLA-7-1465 transcripts have distinct
properties due to their different cytoplasmic tails.
An SLA-7 spliced variant encoding a protein with a
shorter alpha 3 domain
A 1366 nucleotides long transcript was retrieved from
brain RNA and further referred to as SLA-7-1366
(accession number: HQ224544). Surprisingly, annotation
of the cDNA revealed the presence of nine exons due to
a splicing site within exon 4 (Figures 1 and 2). The two
exons matching to exon 4 were named exons 4a and 4b
(Figure 1). Alignment of the SLA-7-1366 cDNA to the
reference genomic sequence showed that between exons
4a and 4b, the donor and acceptor splice sites were GA
and AG, respectively. This finding indicates that a cryp-
tic non canonical splicing code is used to express this
SLA-7 transcript variant. The general rule is the use of
GT and AG for donor and acceptor splicing sites,
respectively [23], but alternative codes may be functional
[24]. It has been shown that the GA-AG splicing site is
rarely used and a few cases have been reported among
which splicing in the human parafibromin gene [25].
Our results suggest that the SLA-7 gene may be subject
to subtle regulation resulting in the use of rarely used
non canonical splicing sites. Additional studies are
required to analyze whether this regulation is tissue-
specific.
The SLA-7-1366 and SLA-7-1465 encoded molecules
with different alpha 3 domain lengths (figures 1 and 2)
i.e. 59 (39 from exon 4a and 20 from exon 4b) and 92
aminoacids long, respectively. The alpha 3 domain cor-
responds to the Immunoglobulin-like region and inter-
acts with the cell surface CD8 glycoproteins that are
expressed on cytotoxic T lymphocytes and function as a
co-receptor with the T cell receptor [26]. Expression of
SLA-7 molecules on the cell surface has not been
demonstrated. However, the alpha 3 domain encoded by
the SLA-7-1366 transcript is shortened by comparison
to the full-length molecule, suggesting that such a modi-
fication may alter interactions with cell receptors.
A spliced variant in the 3’UTR with no alteration of the
encoded protein
By using primers targeting the three prime end of the
gene from exon 4 (SLA-7-e4-F) to the 3UTR (SLA-7-
3UTR-R) (Table 1 and figure 1), two partial transcripts
were recovered that differ in non coding sequence
length (Figure 1). The 650 nucleotide long sequence
(SLA-7-650) corresponds to the expected full-length
sequence. The 464 nucleotide long sequence SLA-7-464
(accession number: GU322919) is the result of an alter-
native splicing within the 3UTR region, 31 nucleotides
downstream to the stop codon. Modification of the
3UTR does not affect the encoded molecules. As
3UTR
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Figure 1 Schematic representation of the SLA-7 transcripts. Exons are numbered E1 to E8 and the three prime non coding region is
indicated as 3UTR. Sizes of exons and 3UTR are given in nucleotides within the boxes. The number of aminoacids for each exon is indicated
above the exon number. Exons represented by a dark blue box (E1) correspond to the leader sequences. Exons represented by orange boxes
(E2 to E4) stand for the alpha1, 2 and 3 domains of the molecules. Exons represented in bright blue (E5) correspond to the transmembrane
domain. Exons represented by green boxes encode the cytoplasmic tail of the molecule. The 3UTR is represented by a grey box. Positions of the
primers used for RT-PCRs are indicated by arrows on top of the figure on E1 (SLA-7-e1-F), E4 (SLA-7-e4-F) and 3UTR (SLA-7-3UTR-R). The donor
and acceptor splice sequences are positioned by arrows on E4 and 3UTR boxes.
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Page 3 of 6indicated in figure 1, the canonical GT-AG rule was
used for this splicing. A new category of transcripts has
been recently characterized that can be subject to non
sense mediated decay (NMD) [27,28]. Variants targeted
by NMD can present alternative splicing in the 3UTR
and the distance between the stop codon and the splice
site has been shown to be more than 50 nucleotides
long [29]. The SLA-7-464 variant cannot fall into this
category of transcripts subject to NMD because the dis-
tance between the stop codon and the splicing site in
only 31 nucleotides. However, it is tempting to hypothe-
size that SLA-7-464 variants are subject to a post-tran-
scriptional regulation that has to be explored.
The expression patterns of these two 3UTR variants
were studied in four different tissues including spleen,
thymus, tonsil, and liver from MeLiM and Large White
pigs. Surprisingly, the SLA-7-650 band was detected in
all tissues of both breeds but the SLA-7-464 band was
detected only in MeLiM pigs (Figure 3). We cannot rule
out a very weak expression of the short variant in Large
White pigs but our results strongly suggest a co-expres-
sion of both variants in MeLiM pigs and a predominant
expression of the SLA-7-650 variant in the Large White
pigs included in our study.
Conclusion and perspectives
We have identified an SLA-7 full length transcript that
had not been characterized before and that differs from
the reference sequence by the length of the encoded
cytoplasmic tail. In addition, we show that the SLA-7
gene is subject to alternative splicing transcription that
leads to either a transcript encoding a molecule with a
SLA-7-1366       MGPQALLLLLSGTLVLTQPWARPHSLRYFYTAVSRPSRRDPRFSVVGYVDDTQFVRFDSS 60
SLA-7-1465      MGPQALLLLLSGTLVLTQPWARPHSLRYFYTAVSRPSRRDPRFSVVGYVDDTQFVRFDSN 60 
SLA_7_001      MGPRALLLLLSGTLVLTQPWARPHSLRYFYTAVSRPSRRDPRFSVVGYVDDTQFVRFDSN 60 
                        ***:*******************************************************. 
SLA-7-1366       APNPREEPRTPWVELEGPEYCDRNTRIYKDTSQNFQVSLNVLRGYYNQSEAGSHTYQWLC 120
SLA-7-1465       APNPREEPRTPWVELEGPEYCDRNTRIYKDTSQNFQVSLNVLRGYYNQSEAGSHTYQWLC 120
SLA_7_001       APNPREEPRTPWVELEGPEYCDRNTRIYKDTSQNFQVSLNVLRGYYNQSEAGSHTYQWLC 120
                        ************************************************************ 
SLA-7-1366       GCYVARDGRLLRGYSQFAYDGADYIALNEDLRSWTAVDMAAQITRRKWEEETVAEQSRAY 180
SLA-7-1465      GCYVARDGRLLRGYSQFAYDGADYIVLNEDLRSWTAVDMAAQITRRKWEEETVAEQSRAY 180
SLA_7_001      GCYVARDGRLLRGYSQFAYDGADYIVLNEDLRSWTAVDMAAQITRRKWEEETVAEQSRAY 180
                        *************************.********************************** 
SLA-7-1366       LEVACVQSLHRYLANGKETLQRSDPPKTHATRHPSSDNKVTLRCWALGFYPKEISLTWQQ 240
SLA-7-1465      LEVACVQSLHRYLVNGKETLQRSDPPKTHVTRHPSSDNKVTLRCWALGFYPKEISLTWQQ 240
SLA 7 001   LEVACVQSLHRYLANGKETLQRSDPPKTHVTRHPSSDNKVTLRCWALGFYPKEISLTWQQ 240 __ QQ QQ
                        *************.***************.****************************** 
SLA-7-1366       EGQ---------------------------------SYTCHVQQEGLQESLTLRWDPPQP 267
SLA-7-1465       EGQDQSQDVEVVETRPSGDGTFQKWAALVVPPGEEQSYTCHVQQEGLQESLTLRWDPPQP 300
SLA_7_001       EGQDQSQDVEVVETRPSGDGTFQKWAALVVPPGEEQSYTCHVQQEGLQESLTLRWDPPQP 300
                        ***                                 ************************ 
SLA-7-1366       PVPIVGIIVGLVLVLVAGAVVTGVVIWRKKCSGGKVRKYQQAERSSRSENSGVCLMPFKA 327
SLA-7-1465      PVPIVGIIVGLVLVLVAGAVVTGVVIWRKKCSGGKVRKYQQAEGSSRSENSGVCLMPFKA 360
SLA_7_001      PVPIVGIIVGLVLVLVAGAVVTGVVIWRKKCSGGKVRKYQQAERSSRSENSGVCLMPFKA 360
                        ******************************************* **************** 
SLA-7_1366      ETLEALSGKQLPYTRRTD------QVTNISLMAL------- 355 
SLA-7-1465              ETLEALSGKQLPYTRRTD------QVTNISLMAL------- 388 
SLA_7_001      ETLEALRWDSGWGRGDTTGLWGFFKWNNLSMWGAVRRSALM 401 
                        ******  ..      *       : .*:*: .         
Figure 2 Multi-alignment of peptides encoded by the transcripts SLA-7-1465, SLA-7-1366 and SLA-7-001. The successive eight (SLA-7-
1366 and SLA-7-1465) or seven (SLA-7-001) exons are alternatively indicated by black and blue font. Aminoacids at the junction between two
exons are in grey boxes. Aminoacid similarities between two or three sequences are indicated below the sequence alignments by dots or stars,
respectively.
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Page 4 of 6shortened alpha 3 domain or a transcript that is spliced
in the 3UTR after the stop codon. In conclusion, the
non classical MHC class Ib gene SLA-7 gene presents a
complex transcription pattern, the regulation of which
needs to be further investigated. The functions of the
putative encoded molecules also need to be studied.
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